Business Wire

CA-NETAPP,-INC.

8.6.2021 14:02:09 CEST | Business Wire | Press release

Share
NetApp Delivers an Innovative, No-Compromise, Unified Hybrid Cloud Experience

NetApp® (NASDAQ: NTAP) a global, cloud-led, data-centric software company, today unveiled a new release of its ONTAP software that powers data services on premises and in the cloud, as well as an array of portfolio updates that leverage ONTAP to provide a flexible foundation for hybrid cloud, unify data management across on-premises and cloud environments, and simplify consumption and operation of hybrid cloud services. As the only provider of hybrid cloud solutions that offers native integration with the world’s leading public clouds, NetApp is unifying management of on-premises and public cloud environments, delivering new ways to consume and operate data services that make it easier for enterprises to put their data to work – wherever and whenever they need it.

The latest enhancements to NetApp’s hybrid cloud portfolio and ONTAP data services include:

  • Flexible Foundations for Hybrid Cloud
    Enterprises need to modernize their IT environments to enable hybrid cloud operations. NetApp is updating its foundational solutions to better support them:

    • FlexPod: The next generation of the globally trusted converged infrastructure platform from NetApp and Cisco provides a better foundation for hybrid cloud with the flexibility to run and manage all your modern workloads. New capabilities include intelligent application placement across on-premises and cloud, automated hybrid cloud data workflows, and the ability to consume FlexPod as a fully managed, cloud-like service.

    • NetApp StorageGRID: The 11.5 release of NetApp’s highly scalable object store now supports data encryption using external key management, offers compliance and ransomware protection with S3 object locks, and delivers increased performance with intelligent load balancing.
  • Simple, Unified Data Management Across Hybrid Cloud Environments
    Managing data and applications in hybrid cloud environments can be extremely challenging – enterprises need a simple, standardized approach. NetApp centralizes data management across the hybrid cloud to make things simpler. NetApp Cloud Manager and enhanced multicloud management services automate ONTAP data services to simplify application migration, disaster recovery, data protection, governance and compliance. In addition, NetApp Astra, an application-aware data service for Kubernetes, enables customers to manage, protect, and migrate stateful applications in Google Cloud, Microsoft Azure – and now on-premises.
  • Cloud-Like Financial Flexibility and Operational Simplicity
    Organizations want the same financial and operational elasticity they get from the cloud in their data center, with the freedom to move and manage workloads easily and securely across hybrid and public cloud environments. The new NetApp Keystone Flex Subscription at Equinix gives customers the ability to deploy Keystone data services in Equinix International Business Exchange™ (IBX®) for low-latency access to multiple clouds – without having to move their data to the cloud. The Keystone Flex Subscription at Equinix is uniquely delivered as a single subscription by NetApp.

“NetApp’s Keystone Flex Subscription at Equinix uniquely provides a flexible, on-demand storage alternative to traditional capex infrastructure investments,” said Royce Thomas, senior vice president, strategic alliances and global account management at Equinix. “With this offering, global businesses can host their data adjacent to the cloud and utilize Equinix Fabric™ to connect to service providers, taking advantage of centralized hybrid cloud data management across all major public clouds.”

“A hybrid cloud strategy is critical to ensuring organizations can keep pace with the growth and complexity of distributed data and applications, thrive in the face of uncertainty and compete effectively in the digital economy,” said Kim Stevenson, senior vice president and general manager, foundational data services business unit at NetApp. “NetApp specializes in helping enterprises at every phase in their digital transformation journeys to implement hybrid cloud strategies and technologies that will help keep them ahead of the curve.”

Additional Resources

About NetApp

NetApp is a global, cloud-led, data-centric software company that empowers organizations to lead with data in the age of accelerated digital transformation. The company provides systems, software and cloud services that enable them to run their applications optimally from data center to cloud, whether they are developing in the cloud, moving to the cloud, or creating their own cloud-like experiences on premises. With solutions that perform across diverse environments, NetApp helps organizations build their own data fabric and securely deliver the right data, services and applications to the right people—anytime, anywhere. Learn more at www.netapp.com or follow us on Twitter , LinkedIn , Facebook , and Instagram .

NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye